Pharmaceutical Business review

XDx files patent reexamination request

The patent purports to claim methods for creating an index of a subject’s biological state pertaining to inflammation. XDx’s request states that a combination of prior art references available before the this patent’s earliest priority date raise substantial new questions about the patentability of certain of the patent’s claims.